---
tags:
  - dermatology
  - Pharmacology
edited: 2024-01-24
---

  - Polyenes: [[Amphotericin B]], Nystatin
  - [[Azoles]]
	  - Fluconazole
	  - Itraconazole
	  - Voriconazole
  - [[Echinocandins]]
	  - Caspofungin
	  - Micafungin
	  - Anidulafungin
- Allylamines
- [[Ciclopirox]] 
- [[Griseofulvin]]
- [[Flucytosine]] 

- [[Antifungals chart.png]] 
- [[Antifungal spectrum.png]]
- [[Antifungal spectrums.png]]

| **Substance Class**        | **Active Substance**         | **Mechanism of Action**                                                                         | **Clinical Use**                                                                                         | **Characteristics**                                                       | **Important Adverse Effects**                                                                                                     |
| -------------------------- | ---------------------------- | ----------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------- |
| **Polyenes**               | Amphotericin B               | Binds to ergosterol in the fungal cell membrane, forming pores that disrupt electrolyte balance | Severe systemic mycoses                                                                                  | Very broad spectrum of efficacy                                           | Toxicity can cause arrhythmias leading to cardiac arrest, phlebitis, electrolyte imbalance, nephrotoxicity                        |
|                            | Nystatin (topical, oral)     | Same as above                                                                                   | Vaginal candidiasis<br>Diaper rash<br>Oropharyngeal candidiasis ("Swish and swallow")                    | Broad spectrum of efficacy                                                | Gastrointestinal symptoms<br>Contact dermatitis, Stevens-Johnson syndrome                                                         |
| **Azoles**                 | Clotrimazole (topical, oral) | Inhibit fungal cytochrome P450, decreasing fungal synthesis of ergosterol from lanosterol       | Primarily topical fungal infections                                                                      | Broad spectrum of efficacy                                                | Local burning, reaction, and/or pruritus                                                                                          |
|                            | Miconazole (topical, oral)   | Same as above                                                                                   | Same as above                                                                                            | Broad spectrum of efficacy                                                | Same as above                                                                                                                     |
|                            | Ketoconazole (topical, oral) | Primarily non-fungal: Psoriasis                                                                 | Same as above                                                                                            | Broad spectrum of efficacy                                                | Hepatotoxicity<br>Inhibition of cytochrome P-450 leading to drug interactions<br>Gastrointestinal upset<br>Gynecomastia           |
|                            | Fluconazole (oral, IV)       | Same as above                                                                                   | Cryptococcal meningitis<br>Candidiasis (all forms)<br>Coccidioidomycosis<br>Histoplasmosis/blastomycosis | Same as above                                                             | Same as above                                                                                                                     |
|                            | Voriconazole (oral, IV)      | Same as above                                                                                   | Invasive aspergillosis<br>Oropharyngeal/esophageal candidiasis<br>Histoplasmosis<br>Blastomycosis        | Same as above                                                             | Same as above                                                                                                                     |
| **Allylamine Derivatives** | Terbinafine (oral, topical)  | Inhibit fungal squalene epoxidase, decreasing ergosterol synthesis                              | Dermatophytosis (especially onychomycosis)<br>Tinea infections (e.g., tinea pedis)                       | Avoid in impaired liver function<br>Avoid in systemic lupus erythematosus | Hepatotoxicity<br>Dysgeusia<br>Gastrointestinal upset<br>Exacerbation of autoimmune diseases (e.g., systemic lupus erythematosus) |
| **Echinocandins**          | Caspofungin (IV)             | Inhibit synthesis of Î²-glucan (a component of the fungal cell wall)                             | Invasive aspergillosis<br>Invasive candidiasis (particularly biofilm-embedded candida)                   | Minimal distribution to the CSF                                           | Flushing<br>Hypotension                                                                                                           |
|                            | Anidulafungin (IV)           | Same as above                                                                                   | Same as above                                                                                            | Same as above                                                             | Same as above                                                                                                                     |
|                            | Micafungin (IV)              | Same as above                                                                                   | Same as above                                                                                            | Same as above                                                             | Same as above                                                                                                                     |
| **Pyridone Derivatives**   | Ciclopirox (topical)         | Disrupt DNA, RNA, and protein synthesis                                                         | Tinea versicolor<br>Dermatophytosis (e.g., onychomycosis)<br>Seborrheic dermatitis of the scalp          | Do not apply to eye or mucous membranes                                   | Facial edema<br>Ventricular tachycardia<br>Skin irritations<br>Pruritus                                                           |
| **Benzofurans**            | Griseofulvin (oral)          | Bind to keratin and interfere with microtubule function, disrupting fungal mitosis              | Oral treatment of tinea infections (e.g., tinea pedis)                                                   | Avoid in porphyria<br>Avoid in hepatic failure                            | Hepatotoxicity<br>Rashes and severe skin reactions (e.g., Stevens-Johnson syndrome)                                               |
| **Antimetabolites**        | Flucytosine (oral)           | Converted to 5-fluorouracil by fungal cytosine deaminase, inhibiting DNA and RNA synthesis      | Monotherapy: select cases of non-life-threatening infections such as genitourinary candida infections    | Use with extreme caution in                                               |                                                                                                                                   |

---
### *Related
- [[Candidiasis]] 
- [[Candidemia]] 